This is a critical abstract of an economic evaluation that meets the criteria for inclusion on NHS EED. Each abstract contains a brief summary of the methods, the results and conclusions followed by a detailed critical assessment on the reliability of the study and the conclusions drawn.
Analysis of effectiveness
The analysis of the clinical study was based on the full sample. The diagnostic outcomes used in the analysis were the correct detection and identification of growths of clinically significant pathogens and agreement in susceptibility results. Standard protocol at the laboratory required that up to 2 potential pathogens detected at levels in excess of 10,000 CFU/mL was considered clinically significant. Three or more were usually reported as "mixed culture". Rapid methods including spot indole, pyrrolidonyl-beta-naphthylamide aminopeptidase, oxidase, coagulase and smell, as described by the National Committee for Clinical Laboratory Standards (NCCLS M35-A), were used for identification alongside "conventional" methods. A Vitek 2 was used for identification where necessary and for susceptibility testing. A MicroScan Walkway was also used for susceptibility testing. The plates were incubated in air at 35 degrees C overnight and read after 10 to 24 hours.
Effectiveness results
Two hundred and fifty (24.4%) of 1,203 urine samples yielded clinically significant results.
For 199 urine cultures (80% of all positive results) the interpretation of growth on CO and standard media was identical.
The remaining 51 cultures, 40 of which produced a pure culture, yielded different interpretations on the two types of media.
Eleven clinically significant organisms were not detected on conventional media, but were on the CO plate. Six organisms detected on standard plates were missing on CO.
The CO plate was correct for 69% of the urine samples for which results did not match. Organisms named on the basis of colony colour and morphologies on CO were in 100% agreement with these organisms as identified from colonies on conventional media.
A total of 2,268 drug-organism combinations were compared during susceptibility testing. Most errors occurred with Klebsiella species, nitrofurantoin and P. aeruginosa, with other errors distributed randomly across species and drugs.
Testing from routine media yielded 14 resistant results (25% of all discordant results) that showed intermediate results from the CO plate.
Clinical conclusions
The authors concluded that CO was easy to use and reliable in the identification of cultures.
Measure of benefits used in the economic analysis
No summary measure of benefits was used. In effect, a cost-consequences analysis was performed.
Direct costs
Discounting was not carried out and was not relevant given the timeframe of the study. The costs were estimated concurrently with effectiveness, but the dates pertaining to resource use and prices were not reported. The costs and the quantities were analysed separately. Resource use included the time spent streaking and labelling one urine culture plate, the time required to perform a complete bench workup on the routine two-plate setup and on the single-plate CO system, the CO, BAP and MacConkey plates and spot test reagents, and the time spent on spot testing. All other setup activities, such as accessioning, removing urine samples from a refrigerator, organising the work area, flaming loops and putting items away, were equal for either conventional or CO urine inoculation and were excluded from the analysis. The quantities were estimated using actual data recorded during the study. Average hourly salaries plus 25% overhead were used to determine the labour costs associated with setup and culture workshop. The costs of materials
